Company · CIK 0001650664 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Editas Medicine, Inc. · EDIT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 SForm 4 → | Sep 4, 4:27 pm EDT | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | 709 | $3.04 | $2,153 | 61,660 | −1.14% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:25 pm EDT | Amy ParisonSVP, Chief Financial Officer | 453 | $3.04 | $1,376 | 13,839 | −3.17% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:22 pm EDT | Gilmore Neil O'NeillCEO, Director | 5,124 | $3.04 | $15,563 | 243,189 | −2.06% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 AForm 4 → | Sep 9, 4:58 pm EDT | Daniel Scott OryEVP, Chief Medical Officer | 950,000 | — | — | 950,000 | — |